C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.51 AUD Market Closed
Market Cap: 167.8m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Cyclopharm Ltd
Investor Relations

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. The company provides diagnostic imaging services specializing in lung health. The firm through its medical device and pharmaceutical products under the name of Technegas, which has become the industry in diagnostic functional lung imaging technology. The company distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. The firm formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Macquarie Medical Imaging (MMI) offers a range of diagnostic radiology, interventional radiology, nuclear medicine and molecular imaging services for inpatient and outpatients. Its Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM
CEO, MD, Company Secretary & Director
No Bio Available
Mr. Mathew Farag
Chief Operating Officer
No Bio Available
Mr. Graham N. Phillips
Finance Manager
No Bio Available
Ms. Sally-Ann Cornelius
Head of Sales
No Bio Available
Ms. Niamh McAree
Head of Quality and Regulatory
No Bio Available
Mr. Chris Quinn
Head of Service
No Bio Available
Ms. Sui Ling Cheah
Financial Controller
No Bio Available
Mr. Lynn McLauchlin
General Manager of Canada
No Bio Available
Mr. Gary T. Somerville
Quality & Regulatory Manager
No Bio Available

Contacts

Address
NEW SOUTH WALES
Unit 4 / 1 The Crescent, Kingsgrove
Contacts